Menopause
Top in women's health: FDA warning for fezolinetant; trauma may be toxic for brain health
The FDA issued a warning that use of fezolinetant can cause rare but serious liver injury following a report of a patient with signs and symptoms of liver injury after taking the nonhormonal medication
‘The mind is medicine’: How virtual reality can cool bothersome hot flashes
CHICAGO — For menopausal women experiencing disruptive, bothersome hot flashes, some relief may come from visiting a snowy landscape by slipping on a virtual reality headset, according to a speaker.
Cognitive behavioral therapy may improve sexual function for menopausal women
CHICAGO — Menopausal women who participated in weekly cognitive behavioral therapy sessions reported improvements in sexual function and depression and anxiety symptoms, researchers reported at the Annual Meeting of The Menopause Society.
Clinical hypnosis consistently halved menopausal hot flash frequency, severity
CHICAGO — A meta-analysis suggests clinical hypnosis is more effective than cognitive behavioral therapy for reducing hot flash frequency and severity for menopausal women, researchers said at the Annual Meeting of The Menopause Society.
Hormone therapy use among menopausal women continues to decline, despite proven safety
CHICAGO — Hormone therapy use among menopausal women has fallen to just 1.8% as of 2023, data show, despite evidence and clinical guidance suggesting HT is safe and effective for most women for bothersome menopausal symptoms.
Female pattern hair loss common during menopause, reversible if promptly treated
CHICAGO — Female pattern hair loss is a common condition for menopausal women, but options to reverse and regrow hair are available if patients are diagnosed and treated, according to a speaker at the Annual Meeting of The Menopause Society.
VIDEO: ‘Less than 1%’ of federal funding goes to menopause research, prompting new program
CHICAGO — In this Healio video exclusive, Susan D. Reed, MD, MPH, MS, past president of The Menopause Society, highlights a new pilot program created to improve funding for research in menopause health, with up to four awards of $25,000 each.
FDA warns of potential liver injury with Veozah for menopausal hot flashes
The FDA issued a warning that use of fezolinetant, a nonhormonal medication indicated for treating menopausal hot flashes, can cause rare but serious liver injury, according to an agency press release.
AI holds ‘transformative potential’ for gynecology, obstetrics and menopause care
CHICAGO — The benefits of AI-assisted technology in medicine are rapidly extending to obstetrics and gynecology, with programs in development or already deployed to predict everything from mode of delivery during labor to cervical cancer risk.
VIDEO: Three takeaways on cognition and brain health during menopause
CHICAGO — In this Healio video exclusive, Pauline M. Maki, PhD, provides three takeaways from her talk on cognition and hormone therapy during menopause at the Annual Meeting of The Menopause Society.